US2006003918A1PendingUtilityA1
Prolonged delivery of peptides
Est. expiryApr 7, 2013(expired)· nominal 20-yr term from priority
A61K 31/4439A61K 38/26C07K 14/605A61K 31/426
62
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
There are disclosed methods for the treatment of non-insulin dependent diabetes mellitus in a mammal comprising the prolonged administration of GLP-1 (7-37), and related peptides. Also disclosed are compositions to prolong the administration of the peptides.
Claims
exact text as granted — not AI-modified1 . A method for the treatment of non-insulin dependent diabetes mellitus in a mammal in need of such treatment comprising the repeated administration over an extended period of time of a compound with prolonged action after each administration, said prolonged action necessary to achieve sustained glycemic control in mammals.
Join the waitlist — get patent alerts
Track US2006003918A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.